Clinical Expert Consensus Statements
Expert consensus statements are documents produced by VASCA-WG specialists to provide agreed, evidence-based guidance on specific clinical questions where formal guidelines do not yet exist or where the evidence base is still emerging.
These statements are primarily intended for healthcare professionals. They are developed through structured expert discussion, drawing on the latest clinical research, and are reviewed and updated when significant new evidence becomes available.
The VASCA-WG is currently working on additional consensus documents covering further conditions and clinical scenarios.
This document is based on the statement elaborated by ASPHO SIG (The American Society of Pediatric Hematology/Oncology Special Interest Group) and CaNVAS (Consortium of iNvestigators of Vascular AnomalieS), USA in December 2023, and further revised by the VASCERN (European Reference Network for Multisystemic Rare Vascular Diseases) VASCA (Vascular Anomalies) working group.
Initiated by the patient advocacy groups in Europe and the United States and their medical advisory teams and approved by the VASCA WG.